Clinical trials - Press Releases

Date	Title	Company
15-Jul-2020	INTELLEGENS AWARDED FUNDING BY INNOVATE UK TO MODEL COVID-19 DATA AND IMPROVE PANDEMIC MANAGEMENT	Intellegens
15-Jul-2020	APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401	APEIRON Biologics and MaxCyte
15-Jul-2020	BAME COMMUNITY AND CORONAVIRUS: OXFORD UNIVERSITY SPIN-OUT ZEGAMI OFFERS MEDICAL PROFESSION ITS DATA VISUALISATION SERVICES FOR FREE TO HELP FIND REASONS WHY BAME PEOPLE ARE AT GREATER RISK FROM CORONAVIRUS	Zegami
15-Jul-2020	EIT Health Wild Card winner attracts 1 million USD investment from Microsoft M12 and Mayfield	EIT Health
15-Jul-2020	Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom	Koura
15-Jul-2020	Major Shareholder Announcement	Genmab
15-Jul-2020	Lipidor signs agreement with CRO for implementation of Phase III clinical study of drug candidate AKP-02 against Psoriasis	Cadila Pharmaceuticals
15-Jul-2020	BAXTER ANNOUNCES PARTNERSHIP WITH ZEOSYS MEDICAL TO BRING INNOVATIVE, ENVIRONMENTALLY FRIENDLY ANAESTHESIA GAS RECAPTURE TECHNOLOGY TO HOSPITALS	Baxter Pharmaceuticals
15-Jul-2020	Enerzair® Breezhaler® (QVM149) receives regulatory approval in Europe and Japan, triggering $6.25 million in milestone payments to Vectura	Vectura
15-Jul-2020	Sosei Heptares notes Enerzair® Breezhaler® approval in the European Union as a treatment for uncontrolled asthma	Sosei Group Corporation
15-Jul-2020	ARRAYJET SECURES $1MILLION BIO PRINTER CONTRACT WITH WORLD’S LARGEST PROTEIN MICROARRAY PRODUCER	Arrayjet
15-Jul-2020	ISPE Announces Formation of New Eurasian Economic Union Affiliate	ISPE
15-Jul-2020	Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe	Ovid Therapeutics
15-Jul-2020	Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate	Medicago
15-Jul-2020	XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke	XBiotech Inc
15-Jul-2020	Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia	Invivoscribe, Inc
15-Jul-2020	Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer	Byondis B.V.
15-Jul-2020	Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner	BaseLaunch
15-Jul-2020	J&J's price reduction of lifesaving TB drug is an important step; governments must scale up use	Johnson & Johnson
15-Jul-2020	Half of British public ‘scared’ of going to hospital due to COVID-19 risk and time-wasting	Incisive Health